Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
1.03
Dollar change
+0.07
Percentage change
6.78
%
Index- P/E- EPS (ttm)-6.27 Insider Own59.27% Shs Outstand7.07M Perf Week-0.96%
Market Cap7.77M Forward P/E- EPS next Y- Insider Trans29.75% Shs Float2.88M Perf Month-8.85%
Income-44.34M PEG- EPS next Q- Inst Own2.44% Short Float0.37% Perf Quarter-22.56%
Sales20.69M P/S0.38 EPS this Y- Inst Trans-5.88% Short Ratio0.49 Perf Half Y-36.80%
Book/sh7.38 P/B0.14 EPS next Y- ROA-26.14% Short Interest0.01M Perf Year-60.38%
Cash/sh1.54 P/C0.67 EPS next 5Y- ROE-60.57% 52W Range0.86 - 3.08 Perf YTD-57.12%
Dividend Est.- P/FCF- EPS past 5Y- ROI-67.17% 52W High-66.56% Beta1.75
Dividend TTM- Quick Ratio1.11 Sales past 5Y22.41% Gross Margin-18.28% 52W Low20.44% ATR (14)0.10
Dividend Ex-Date- Current Ratio1.16 EPS Y/Y TTM43.27% Oper. Margin-88.36% RSI (14)48.01 Volatility10.55% 9.30%
Employees95 Debt/Eq1.24 Sales Y/Y TTM-40.40% Profit Margin-214.27% Recom1.00 Target Price16.00
Option/ShortNo / Yes LT Debt/Eq0.27 EPS Q/Q-20.74% Payout- Rel Volume22.48 Prev Close0.96
Sales Surprise-26.98% EPS Surprise-50.00% Sales Q/Q33.88% Earnings- Avg Volume21.69K Price1.03
SMA202.99% SMA50-10.72% SMA200-31.72% Trades Volume487,504 Change6.78%
Date Action Analyst Rating Change Price Target Change
Jun-24-20Initiated Aegis Capital Buy $14
Jul-22-13Initiated Dawson James Buy $4
Sep-16-24 04:26PM
Sep-10-24 09:00AM
Aug-26-24 04:08PM
Jan-30-24 08:05AM
Jan-04-24 08:15AM
04:30PM Loading…
Dec-22-23 04:30PM
Nov-28-23 08:10AM
Nov-15-23 01:57PM
Nov-14-23 08:00AM
Nov-08-23 08:31AM
Oct-26-23 05:25PM
Oct-23-23 08:25AM
Oct-12-23 08:25AM
Sep-06-23 08:40AM
Aug-29-23 05:40AM
08:15AM Loading…
Jul-31-23 08:15AM
Jul-27-23 09:00AM
Jul-12-23 09:00AM
Jul-05-23 08:15AM
Jun-30-23 09:34AM
Jun-27-23 09:15AM
Jun-26-23 08:20AM
Jun-13-23 07:00AM
May-17-23 11:07AM
May-16-23 09:00AM
May-01-23 08:25AM
Apr-19-23 09:08AM
Apr-18-23 07:00AM
Apr-17-23 10:00AM
Apr-11-23 09:10AM
09:00AM Loading…
Mar-27-23 09:00AM
Mar-22-23 08:05AM
Mar-13-23 09:25AM
Mar-07-23 09:25AM
Mar-02-23 08:30AM
Nov-17-22 10:05AM
Oct-19-22 08:00AM
Sep-22-22 09:15AM
Aug-30-22 04:45PM
Jul-26-22 08:00AM
Jul-21-22 05:00PM
Jul-13-22 08:00AM
Jun-28-22 08:00AM
Jun-07-22 07:00AM
May-19-22 11:10AM
May-06-22 08:30AM
Apr-07-22 10:15AM
Mar-03-22 08:00AM
Feb-28-22 05:15PM
08:00AM
Feb-22-22 05:00PM
Jan-25-22 04:30PM
Jan-20-22 08:45AM
Jan-19-22 03:57PM
12:13PM
Jan-12-22 08:30AM
Jan-11-22 10:00AM
Jan-10-22 08:30AM
Jan-03-22 11:04AM
Dec-22-21 07:30AM
Dec-20-21 10:10AM
Dec-15-21 07:30AM
Dec-07-21 07:30AM
07:00AM
Dec-01-21 05:15AM
Nov-30-21 07:30AM
Nov-04-21 09:00AM
Oct-28-21 08:00AM
Oct-20-21 08:00AM
Oct-05-21 08:00AM
Sep-20-21 07:30AM
Sep-13-21 09:32AM
Sep-09-21 07:00AM
Sep-08-21 07:00AM
Sep-07-21 08:00AM
Sep-02-21 06:25AM
Aug-23-21 01:52PM
09:00AM
Aug-17-21 08:30AM
Aug-02-21 09:45AM
Jul-27-21 08:00AM
Jul-12-21 08:00AM
Jul-06-21 08:30AM
Jun-30-21 08:30AM
Jun-24-21 09:10AM
Jun-17-21 10:00AM
09:46AM
Jun-16-21 09:00AM
Jun-15-21 08:54AM
Jun-14-21 08:08PM
May-24-21 09:31AM
May-20-21 12:15PM
May-19-21 08:30AM
May-11-21 08:45AM
Apr-21-21 06:55AM
Apr-19-21 05:00AM
Apr-08-21 09:05AM
Apr-07-21 09:15AM
Apr-06-21 12:39PM
09:05AM
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chan Heng Fai AmbroseDirectorDec 10 '24Buy0.97820,597800,0003,961,211Dec 12 09:49 PM
Chan Heng Fai AmbroseDirectorDec 10 '24Buy0.97205,149200,0001,184,475Dec 12 09:49 PM
DSS, INC.10% OwnerNov 18 '24Sale3.025,00015,08553,100Nov 22 04:33 PM
DSS, INC.10% OwnerNov 12 '24Sale2.765001,37858,300Nov 22 04:33 PM
DSS, INC.10% OwnerNov 13 '24Sale2.8020056058,100Nov 22 04:33 PM
DSS, INC.10% OwnerSep 18 '24Buy2.331,0002,33058,800Sep 19 07:07 PM
DSS, INC.10% OwnerSep 16 '24Buy2.6950,000134,50050,000Sep 18 08:53 PM
DSS, INC.10% OwnerSep 17 '24Buy2.407,80018,72057,800Sep 18 08:53 PM
Wu William Wai LeungDirectorDec 29 '23Sale0.13150,00019,6500Jan 02 04:15 PM
Wu William Wai LeungDirectorDec 29 '23Sale0.131,0201340Jan 02 04:15 PM
Chan Heng Fai AmbroseDirectorDec 28 '23Buy0.15672,17398,13719,586,499Jan 02 09:10 AM